Statistical Considerations of Food Allergy Prevention Studies

被引:10
作者
Bahnson, Henry T. [1 ]
du Toit, George [2 ,3 ]
Lack, Gideon [2 ,3 ]
机构
[1] Benaroya Res Inst, Immune Tolerance Network, Seattle, WA USA
[2] Kings Coll London, Div Asthma Allergy & Lung Biol, Dept Pediat Allergy, London, England
[3] Guys & St Thomas NHS Fdn Trust, London, England
基金
美国国家卫生研究院;
关键词
Prevention studies; Food allergy; Statistical considerations; Complier average causal effect; LEAP; EAT; Dilution effects; Dropout; Imputation; Missing data; Tipping point analysis; Type I error; Type II error; PRINCIPAL STRATIFICATION; CLINICAL-TRIALS; PEANUT ALLERGY; TESTS; POWER; NONCOMPLIANCE; INFANTS; RISK;
D O I
10.1016/j.jaip.2016.12.007
中图分类号
R392 [医学免疫学];
学科分类号
100102 ;
摘要
Clinical studies to prevent the development of food allergy have recently helped reshape public policy recommendations on the early introduction of allergenic foods. These trials are also prompting new research, and it is therefore important to address the unique design and analysis challenges of prevention trials. We highlight statistical concepts and give recommendations that clinical researchers may wish to adopt when designing future study protocols and analysis plans for prevention studies. Topics include selecting a study sample, addressing internal and external validity, improving statistical power, choosing alpha and beta, analysis innovations to address dilution effects, and analysis methods to deal with poor compliance, dropout, and missing data. (C) 2017 The Authors. Published by Elsevier Inc. on behalf of the American Academy of Allergy, Asthma & Immunology.
引用
收藏
页码:274 / 282
页数:9
相关论文
共 30 条
  • [1] Inferences and power analysis concerning two negative binomial distributions with an application to MRI lesion counts data
    Aban, Inmaculada B.
    Cutter, Gary R.
    Mavinga, Nsoki
    [J]. COMPUTATIONAL STATISTICS & DATA ANALYSIS, 2009, 53 (03) : 820 - 833
  • [2] [Anonymous], J ALLERGY CLIN IMMUN
  • [3] Update on food allergy
    Carrard, A.
    Rizzuti, D.
    Sokollik, C.
    [J]. ALLERGY, 2015, 70 (12) : 1511 - 1520
  • [4] REDUCTION IN BURDEN OF ILLNESS - A NEW EFFICACY MEASURE FOR PREVENTION TRIALS
    CHANG, MN
    GUESS, HA
    HEYSE, JF
    [J]. STATISTICS IN MEDICINE, 1994, 13 (18) : 1807 - 1814
  • [5] Employing Complier Average Causal Effect Analytic Methods to Examine Effects of Randomized Encouragement Trials
    Connell, Arin M.
    [J]. AMERICAN JOURNAL OF DRUG AND ALCOHOL ABUSE, 2009, 35 (04) : 253 - 259
  • [6] Randomized Trial of Peanut Consumption in Infants at Risk for Peanut Allergy
    Du Toit, George
    Roberts, Graham
    Sayre, Peter H.
    Bahnson, Henry T.
    Radulovic, Suzana
    Santos, Alexandra F.
    Brough, Helen A.
    Phippard, Deborah
    Basting, Monica
    Feeney, Mary
    Turcanu, Victor
    Sever, Michelle L.
    Lorenzo, Margarita Gomez
    Plaut, Marshall
    Lack, Gideon
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2015, 372 (09) : 803 - 813
  • [7] Dubey S D, 1991, J Biopharm Stat, V1, P139, DOI 10.1080/10543409108835011
  • [8] Estimating treatment effects from randomized clinical trials with noncompliance and loss to follow-up: the role of instrumental variable methods
    Dunn, G
    Maracy, M
    Tomenson, B
    [J]. STATISTICAL METHODS IN MEDICAL RESEARCH, 2005, 14 (04) : 369 - 395
  • [9] Impact of peanut consumption in the LEAP Study: Feasibility, growth, and nutrition
    Feeney, Mary
    Du Toit, George
    Roberts, Graham
    Sayre, Peter H.
    Lawson, Kaitie
    Bahnson, Henry T.
    Sever, Michelle L.
    Radulovic, Suzana
    Plaut, Marshall
    Lack, Gideon
    [J]. JOURNAL OF ALLERGY AND CLINICAL IMMUNOLOGY, 2016, 138 (04) : 1108 - 1118
  • [10] Fisher L D, 1991, J Biopharm Stat, V1, P151, DOI 10.1080/10543409108835012